IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SALANI, SABRINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.591
NA - Nord America 6.527
AS - Asia 5.737
Continente sconosciuto - Info sul continente non disponibili 922
SA - Sud America 470
AF - Africa 136
OC - Oceania 32
Totale 20.415
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.176
GB - Regno Unito 2.060
CN - Cina 1.703
SG - Singapore 1.533
IT - Italia 1.074
DE - Germania 919
BD - Bangladesh 737
SE - Svezia 609
HK - Hong Kong 453
VN - Vietnam 419
RU - Federazione Russa 418
FR - Francia 370
BR - Brasile 307
CA - Canada 269
IN - India 257
FI - Finlandia 230
UA - Ucraina 215
NL - Olanda 182
KR - Corea 178
IE - Irlanda 163
TR - Turchia 153
EU - Europa 115
JP - Giappone 77
DK - Danimarca 70
CO - Colombia 68
CI - Costa d'Avorio 64
PL - Polonia 64
ID - Indonesia 63
BE - Belgio 42
GR - Grecia 37
AR - Argentina 34
ES - Italia 27
AU - Australia 26
MX - Messico 25
AT - Austria 19
RO - Romania 18
CH - Svizzera 17
EC - Ecuador 17
IQ - Iraq 17
ZA - Sudafrica 17
TW - Taiwan 15
MA - Marocco 14
AZ - Azerbaigian 13
CL - Cile 13
CZ - Repubblica Ceca 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
PK - Pakistan 11
VE - Venezuela 11
PH - Filippine 10
CR - Costa Rica 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
JM - Giamaica 8
HN - Honduras 7
HU - Ungheria 7
KE - Kenya 7
MY - Malesia 7
HR - Croazia 6
IR - Iran 6
NZ - Nuova Zelanda 6
PE - Perù 6
PY - Paraguay 6
DO - Repubblica Dominicana 5
EE - Estonia 5
LK - Sri Lanka 5
NP - Nepal 5
PS - Palestinian Territory 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
LB - Libano 4
LT - Lituania 4
NI - Nicaragua 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BB - Barbados 3
BY - Bielorussia 3
CM - Camerun 3
GA - Gabon 3
GT - Guatemala 3
LV - Lettonia 3
OM - Oman 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
GE - Georgia 2
GL - Groenlandia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
NG - Nigeria 2
PA - Panama 2
SC - Seychelles 2
SV - El Salvador 2
Totale 19.581
Salva come PNG Salva come JPEG
Città #
Southend 1.763
Singapore 908
Ashburn 738
Chandler 544
Hong Kong 423
Beijing 368
San Jose 319
Milan 306
Dallas 252
Council Bluffs 243
Seattle 210
Santa Clara 200
Wilmington 198
Houston 188
Princeton 187
Los Angeles 167
Ann Arbor 158
Dublin 156
Jacksonville 149
Toronto 139
Fairfield 127
New York 126
Bengaluru 117
Helsinki 111
Ho Chi Minh City 109
Boardman 101
Frankfurt am Main 101
Woodbridge 101
Buffalo 84
Nanjing 83
Redmond 83
Hanoi 81
Lauterbourg 79
Mountain View 66
Shanghai 64
Abidjan 63
Des Moines 63
Munich 63
Grafing 61
Dearborn 56
Somerville 56
Warsaw 56
Bogotá 54
Moscow 54
Sakarya 54
Andover 53
Guangzhou 52
Phoenix 52
Shenyang 51
Serra 49
Dong Ket 48
Rome 48
The Dalles 48
Hefei 47
Cambridge 45
Tokyo 44
Redwood City 41
Jakarta 39
Jinan 39
Changsha 38
Brussels 36
Kiez 36
Ottawa 36
Columbus 34
Turku 33
Nanchang 32
Hangzhou 30
Medford 30
London 29
São Paulo 29
Bitonto 28
Cangzhou 28
Istanbul 27
Naples 27
Hanover 26
Montreal 25
Athens 24
Hebei 24
Fuzhou 22
Atlanta 20
Florence 20
Ningbo 20
Seoul 20
Zhengzhou 20
Berlin 19
Chicago 19
Palo Alto 17
Quanzhou 17
Seongnam 17
Turin 17
Brooklyn 16
Nürnberg 16
San Diego 16
Bari 15
Bologna 15
Da Nang 15
Falkenstein 15
Jiaxing 15
New Delhi 15
Tianjin 15
Totale 11.238
Salva come PNG Salva come JPEG
Nome #
Loss of the nucleoporin Aladin in central nervous system and fibroblasts of Allgrove Syndrome 540
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons 463
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 437
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 399
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 397
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 384
A novel homozygous VPS11 variant may cause generalized dystonia 351
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of Andersen Disease associated with a new mutation in GBE1 gene 344
Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies 325
The mitochondrial disulfide relay system protein GFER is mutated in autosomal recessive myopathy with congenital cataract and COX deficiency. 320
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 306
The mitochondrial disulfide relay system protein GFER is mutated in sutosomal-tecessive myopathy with vataract and vombined respiratory-chain deficiency 300
Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction 294
Dystonia-ataxia syndrome with permanent torsional nystagmus caused by ECHS1 deficiency 284
Transplanted ALDH(hi)SSC(lo) neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1 281
Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients 275
Embryonic stem cell–derived neural stem cells improve spinal muscular atrophy phenotype in mice 266
Motor neurons from human spinal muscular atrophy–induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 262
Autosomal dominant and recessive limb-girdle muscular dystrophies : clinical, genetic relative frequency in a large Italian population 260
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 260
Neuropathological study of skeletal muscle, heart, liver, and brain in a neonatal form of Andersen disease associated with a new mutation in GBE gene 259
Mitochondrial dysfunction in fibroblasts of Multiple System Atrophy 253
Motoneuron Transplantation Rescues the Phenotype of SMARD1 (Spinal Muscular Atrophy with Respiratory Distress Type 1) 246
Limb-Girdle muscular dystrophies : clinical features and genetic frequency in a large Italian population 244
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired 241
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 238
In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells : Evidence of programmed cell death after muscle cell transplantation 235
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin 234
Direct reprogramming of human astrocytes into neural stem cells and neurons 233
A novel MAPT mutation associated to late-onset spinal muscular atrophy without dementia in a large Italian family 230
Antisense Morpholino-Based In Vitro Correction of a Pseudoexon-Generating Variant in the SGCB Gene 228
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 226
Skeletal muscle differentiation potential of human adult bone marrow cells 220
Development of cellular and molecular therapeutic approaches for spinal muscular atrophy with respiratory di stress (SMARD1) 217
A novel MAPT mutation associated to late-onset spinal muscular atrophy without dementia in a large Italian family 216
Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy 214
Motoneurons from human spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 214
A Subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse 213
Pluripotent engineered stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice 205
Transplantation of neural stem cells derived from engineered ESC lineage (sox2-βgeo/oct4-tk cells) improves the phenotype of a mouse model of Spinal Muscular Atrophy 201
Novel SOD1 Q23R mutation associated with muscle mitochondrial dysfunction in familial ALS International Meeting “Mutant SOD1 and familial ALS: from the molecule to man 199
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 199
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 197
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 197
Clinical, molecular and protein correlations in a large sample of genetically diagnosed limb girdle muscular dystrophy patients 195
Cellule staminali neuronali derivate da staminali embrionali murine migliorano il fenotipo di un modello murino di Atrofia Spinale Muscolare (SMA)”. 195
Transplantation of an ALDHhiSSCio population as a potential therapy os spinal muscular atrophy 194
Fas siRNA mediated interference reduces motor neuron death in amyotrophic lateral sclerosis mouse model 194
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 193
Generation and characterization of iPSC-derived cortical pyramidal neurons from patients affected by multiple system atrophy 193
HB9-Positive Neural Stem Cell-Derived Motor Neurons Improve Disease Phenotype after Transplantation into a SMARD1 Animal Model 188
Neural stem cell intratechal transplantation ameliorates the phenotype of a spinal muscular atrophy murine model. 187
Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation 187
Soft cerebellar signs unveil RARS2‐related epilepsy 186
Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity 185
Motoneuron transplantation rescue the phenotype of spinal muscular atrophy with respiratory distress type 1 (SMARD1) 183
Motoneuron transplantation rescues the phenotype of spinal muscular atrophy with respiratory distress type 1 180
Directing human astrocytes into neural stem cells and neurons as possible tool for repair in CNS diseases 180
A biallelic variant in COX18 cause isolated Complex IV deficiency associated with neonatal encephalo-cardio-myopathy and axonal sensory neuropathy 179
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis 179
Transplanted neural stem cell-derived motor neurons improve SMARD1 disease phenotype 178
Adult polyglucosan body disease: clinical and histological heterogeneity of a large Italian family 178
Pluripotent stem cell-based models of spinal muscular atrophy 178
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons 178
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 176
Transplantation of ALDH expressing neuronal stem cell subpopulation derived from spinal cord into Nmd mice, an animal model of SMARD1 174
Neuroprotection in spinal muscular atrophy (SMA) using neural stem cells as a therapeuthic approach 174
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 174
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms 173
Neural stem cells derived from genetically engineered lineage-selectable Es cells improves the phenotype of a mouse model of spinal muscular atrophy 172
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 172
Gene Corrected Spinal Muscular Atrophy-Induced Pluripotent Stem Cells and Motoneuron as a Model and Cell Source for Transplantation (IN8-2.002) 172
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies 170
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms 169
Transplantation of LeX+/CXCR4+ adult neural stem cells delays disease progression of SOD1 mice, an animal model of amyotrophic lateral sclerosis (ALS) 167
Stem Cell-derived motoneurons rescue the phenotype of spinal muscular atrophy with respiratory distress type 1 (SMARD1) 167
Neuropathological study of skeletal muscle, heart, liver, and brainin a neonatal form of glycogen storage disease type IV associated with a newmutation in GBE1 gene 160
Prominent muscle involvement in a familial form of mitochondrial disease due to a COA8 variant 159
Hepatic and neuromuscular forms of glycogenosis Type III : nine mutations in AGL Gene 159
Transplantation of LeX+/CXCR4+ adult neural stem cells in the spinal cord of a murine model of amyotrophic lateral sclerosis 157
The mitochondrial disulfide relay system protein GFER is mutated in autosomal recessive myopathy with congenital cataract and COX deficiency 156
Generation of motoneurons from spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences : in vitro and In vivo analysis 153
SOX2-Dependent Dedifferentiation of Human Astrocytes in Multipotent Stem Cells as Possible Cell Source for Repair in CNS Diseases 150
Si-Rna silencing interfers on motor neuron degeneration of SOD1 G93A ALS mouse model 150
Neural stem cell population deriving from SOX2-dependent dedifferentiated human astrocytes as possible cell source for cell mediated therapy in neurodegenerative diseases 149
Transplantation of neural stem cells derived from genetically engineered, lineage-selectable ES cells improves spinal muscular atrophy 149
Transcriptomic characterization of tissues from patients and subsequent pathway analyses reveal biological pathways that are implicated in spastic ataxia 148
Systemic transplantation of c-kit+ cells can ameliorate the phenotype of a mouse model of Amyotrophic Lateral Sclerosis 145
In vitro and in vivo analysis of motoneurons obtained from human-spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences 143
siRNA Mediated Interference of Motoneuron Death Triggered by Fas in SOD1 G93A ALS Mouse Model. 141
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 129
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 114
Characterization of Skeletal Muscle Biopsy and Derived Myoblasts in a Patient Carrying Arg14del Mutation in Phospholamban Gene 107
Expanding the genetic landscape of Dusty Core Disease: new RYR1 variants in Italian patients 26
null 4
null 3
null 3
null 3
null 3
null 3
Totale 20.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.105 0 0 58 85 60 97 81 60 182 148 110 224
2022/20231.670 201 209 147 206 199 299 49 88 187 16 45 24
2023/20241.064 35 67 68 97 299 67 44 65 41 49 93 139
2024/20252.627 95 202 79 334 185 85 69 225 162 280 274 637
2025/20265.806 579 329 569 429 462 351 611 205 513 402 781 575
2026/2027856 382 380 94 0 0 0 0 0 0 0 0 0
Totale 20.415